Categories: News

Visionary Foundation 2023 Impact Statement on Surgical Mission

2023 Impact Statement of the Honduras Surgical Eye Mission

WASHINGTON, DC / ACCESSWIRE / September 11, 2023 / The Visionary Foundation and Dr. Alberto Martinez, MD, conducted a highly successful surgical mission in San Pedro Sula, Honduras, from August 10th to August 14th, 2023, at the FSMV Hospital Leonardo Martinez, with support from FSMV charity led by Dr. Marcos Fajardo.

During this mission, Dr. Martinez, with the assistance of Dr. Edgar Maldonado, streamlined the surgical process, resulting in a record-breaking mission. They completed 17 corneal transplants, 43 cataract extractions, and five complex triple procedures, setting a new benchmark for the Visionary Foundation.

Remarkable cases included a successful corneal transplant for an 8-year-old boy and a challenging cataract surgery for a 14-year-old boy, both showing excellent outcomes.

Looking ahead to future missions, the foundation aims to improve instrument quality, streamline customs paperwork, secure funding for a new microscope, and collaborate with corneal banks to meet the growing demand for corneas.

The mission’s success was made possible thanks to the generous support of Cornea Gen Tissue Bank, AltruVision A Lions Eye Bank, Alcon Laboratories, dedicated individuals like Nancy Cruz, Kevin Smith, Loretta Spence, and the kind contributions of Anna Pigotti and Matthew Martinez.

Additionally, the foundation extended its philanthropic efforts, donating $5,000 and school supplies to “Hogar San Jose,” an orphanage directed by Sister Cilia.

To contribute to their vital work, please visit the Visionary Foundation’s website: https://www.visionaryfoundation.net/donate/

Contact Information

Katia Carpio
Marketing Director
kcarpio@voeyedr.com
+12404639026

SOURCE: Visionary Foundation

View source version on accesswire.com:
https://www.accesswire.com/782341/visionary-foundation-2023-impact-statement-on-surgical-mission

Staff

Recent Posts

CelLBxHealth PLC Announces Board Changes

GUILDFORD, SURREY / ACCESS Newswire / January 12, 2026 / CelLBxHealth plc (AIM:CLBX), a leader…

28 minutes ago

Cosmo Enters Scale Up Phase with 104M Revenue, 128M Cash, and Breakout AI and Dermatology Platforms

Ad hoc announcement pursuant to Art. 53 LR 2025 marks a key execution year in…

1 hour ago

Pre-JPM Investor Pulse Signals 2026 Capital Rotation Toward “AI That Ships,” Admin Cost Takeout, and Differentiated Metabolic Assets With Special-Situations Capital Back in Scope

Preliminary, directional read of planned 88-investor sample indicates heightened proof thresholds (unit economics, reimbursement, outcomes)…

15 hours ago

Best GLP-1 Weight Loss Shot (2026): Direct Meds Reviews Prescription Access Pathways as New GLP-1 Formats Expand

LegitScript-certified telehealth platform publishes consumer analysis as searches for GLP-1 weight loss information reach record…

18 hours ago

Nutri Derma Guard Skin Tag Remover Ingredients Investigated: 2026 Analysis Examines Formulation And Consumer Disclosures

Independent investigation examines castor oil, tea tree oil, and salicylic acid formulation claims in the…

18 hours ago